Trial Details
RECRUITINGBasic Information
| Clinical ID | c10 |
|---|---|
| Identifier | NCT07442045 |
| Trial Title | Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Upadacitinib|DRUG: Vedolizumab |
Participant Information
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
|---|---|
| City | Guangdong |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2023-01-01 |
|---|---|
| Primary Completion Date | 2025-09-30 |
| Completion Date | 2026-06-01 |